Nu Skin Enterprises Provides Business Update And Announces 50 Percent Increase In Dividend

Nu Skin Enterprises Provides Business Update And Announces 50 Percent Increase
                                 In Dividend

PR Newswire

PROVO, Utah, Dec.18, 2012

PROVO, Utah, Dec.18, 2012 /PRNewswire/ --Nu Skin Enterprises, Inc. (NYSE:
NUS) today announced that it plans to increase its regularly scheduled
dividend payments by 50 percent for 2013. With this planned increase, the
company will have increased dividends for each of the 12 consecutive years
since it instituted the payment of dividends to stockholders.

"We have generated record results for each of the past five years and believe
2013 will be another record year," said Truman Hunt, president and chief
executive officer. "Based on our consistent growth and our commitment to
return capital to stockholders, we expect to increase our 2013 dividend by 50
percent, which would represent a 140 percent increase in dividends over the
past three years. With our strong performance and increasing cash flow, we
have the financial flexibility to increase dividends, repurchase shares and
continue to invest in important business initiatives to sustain revenue

Beginning with its regular first quarter dividend in 2013, the company
currently expects to pay a quarterly dividend of $0.30 per share, or $1.20 per
year, compared to the previous quarterly dividend of $0.20 per share, or $0.80
per year.

Nu Skin also provided an update on its ongoing Japan customs case. The Tokyo
High Court recently affirmed the lower court's decision with respect to the
company's lawsuit to recover approximately $33 million in customs duties
assessed against the company for the period of 2002 through 2005. Nu Skin
continues to disagree with this decision and has appealed to the Supreme Court
of Japan. The recent decision will not impact the company's financial results
as it previously paid and recorded as an expense the full amount of this

About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its
comprehensive anti-aging product portfolio, independent business opportunity
and corporate social responsibility initiatives. The company's scientific
leadership in both skin care and nutrition has established Nu Skin as a
premier anti-aging company. The company's anti-aging products feature the new
ageLOC^® suite of products including the ageLOC^® R^2 nutritional supplement,
ageLOC^® Galvanic Spa System and ageLOC^® Galvanic Body Spa™, as well as the
ageLOC^® Transformation daily skin care system. A global direct selling
company, Nu Skin operates in 53 markets worldwide and has more than 900,000
active distributors and preferred customers. Nu Skin is traded on the New York
Stock Exchange under the symbol 'NUS'. More information is available at

Please Note: This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended that represent the
company's current expectations and beliefs. All statements other than
statements of historical fact are "forward-looking statements" for purposes of
federal and state securities laws and include, but are not limited to,
statements of management's expectations regarding the company's initiatives
and strategies, statements of projections regarding the company's performance,
cash flow from operations, the amount and timing of future dividend payments
and other financial items; statements of the company's plans and expectations
regarding its ongoing Japan customs litigation; statements of belief; and
statements of assumptions underlying any of the foregoing. In some cases, you
can identify these statements by forward-looking words such as "believe,"
"expect," "project," "anticipate," "estimate," "intend," "plan," "targets,"
"likely," "will," "would," "could," "may," "might," the negative of these
words and other similar words.

The forward-looking statements and related assumptions involve risks and
uncertainties that could cause actual results and outcomes to differ
materially from any forward-looking statements or views expressed herein.
These risks and uncertainties include, but are not limited to, the following:

  othe actual declaration and payment of the planned dividends by the Board
    of Directors is subject to any changes in the company's net earnings,
    financial condition, cash requirements, future prospects or other factors
    deemed relevant by the company's board of directors that could cause the
    Board of Directors to reduce or discontinue the payment of currently
    planned quarterly dividends;
  oany failure of current or planned initiatives or products to generate
    interest among distributors and customers and generate sponsoring and
    selling activities on a sustained basis;
  orisks related to accurately predicting, delivering or maintaining
    sufficient quantities of products to support our planned initiatives or
    launch strategies, including possible ingredient supply limitations;
  ochallenging economic conditions globally;
  orisk of foreign currency fluctuations and the currency translation impact
    on the company's business associated with these fluctuations;
  orisks associated with general inquiries and complaints to consumer
    protection agencies in Japan regarding the activities of some
  oregulatory risks associated with the company's products, which could
    require the company to modify its claims or inhibit the company's ability
    to import or continue selling a product in a market if it is determined to
    be a medical device or if it is unable to register the product in a timely
    manner under applicable regulatory requirements;
  ocontinued regulatory scrutiny and investigations in Mainland China, which
    have from time to time in the past, and could in the future, negatively
    impact the company's business, including the interruption of sales
    activities in stores, loss of licenses, and the imposition of fines;
  oadverse publicity related to the company's business, products, industry or
    any legal actions or complaints by distributors or others;
  oany prospective or retrospective increases in duties on the company's
    products imported into the company's markets outside of the United States
    and any adverse results of tax audits or unfavorable changes to tax laws
    in the company's various markets; and
  ocontinued competitive pressures in the company's markets.

The company's financial performance and the forward-looking statements
contained herein are further qualified by a detailed discussion of associated
risks set forth in the documents filed by the company with the Securities and
Exchange Commission. The forward-looking statements set forth the company's
beliefs as of the date that such information was first provided and the
company assumes no duty to update the forward-looking statements contained in
this release to reflect any change except as required by law.

SOURCE Nu Skin Enterprises, Inc.

Contact: Investors: Scott Pond, 801-345-2657,; or Media: Kara
Schneck 801-345-2116,
Press spacebar to pause and continue. Press esc to stop.